• Andrew Reed, PhD, has joined CardioTech International (Wilmington, Massachusetts) as vice president of technology in charge of CardioPass coronary artery bypass development and biomaterials. The company called Reed a “world expert” in the area of biocompatible and biodurable polyurethanes. He was instrumental in the development of synthetic polyurethane vascular grafts using the phase inversion fabrication technique. He also is the inventor of Mitraflex microporous polyurethane membrane-based wound-healing products. Reed was formerly executive vice president, operations for the Specialty Products Division of CCS Medical. CardioTech is a manufacturer of advanced medical device products treating cardiovascular disease.

• James Toscano will replace Ford Watson Bell as president of the Minneapolis Heart Institute Foundation. Bell resigned last fall to focus on his campaign for the U.S. Senate. Toscano will join the foundation this month from Park Nicollet Institute, where he has served as executive vice president since 1981 and is credited with leading several initiatives to improve and expand clinical research, education, outreach and professional training. The Minneapolis Heart Institute Foundation is an independent, not-for-profit, community-based research and education organization.

• Silvia Scuri has been named director of marketing, communication and scientific support for ventricular assist device firm NewCorTec (Pomezia, Italy). She has held various senior management positions in the healthcare industry, including work in the field of heart-assist devices with Baxter/Edwards Lifesciences/Novacor, and has contributed significantly, NewCorTec said, to the opening and broadening of the VAD market in Europe. The company cited Scuri’s experience in the field as being of “crucial importance” to the start of its clinical trials for the device, anticipated for the second half of this year. NewCorTec said its animal tests should be completed by mid-summer.